Surgical sealant to be assessed in Europe:
This article was originally published in Clinica
Cohesion Technologies of Palo Alto, California, has begun a European feasibility study to assess its new product for preventing blood leaks in cardiovascular and vascular surgery. CoSeal surgical sealant, a totally synthetic gel which polymerises at the surgical site in seconds, takes about five minutes to prepare and completely resorbs within 30 days. The product will be tested in up to 15 patients undergoing peripheral vascular surgery. Palo Alto-based Cohesion's first product, CoStasis, a surgical haemostat to treat diffuse bleeding, is already available in certain European countries and is expected to be submitted for US marketing approval by spring 1999.